PulseAugur
EN
LIVE 09:44:27
中文(ZH) 公司有意于阿布扎比进行第二上市?英矽智能回应

Insilico Medicine addresses Abu Dhabi secondary listing rumors

Insilico Medicine has addressed recent media reports suggesting a potential secondary listing in Abu Dhabi. While the company stated it continuously evaluates capital operations, including secondary listings, it currently has no concrete plans for such a move. Insilico Medicine will make further announcements if significant developments occur. AI

IMPACT Company is addressing market speculation regarding its financial operations.

RANK_REASON The item discusses a company's response to rumors about a potential stock listing, which is not a core AI event.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Insilico Medicine addresses Abu Dhabi secondary listing rumors

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Is Insilico Medicine Planning a Second Listing in Abu Dhabi? Insilico Medicine Responds

    36氪获悉,英矽智能公告,公司董事会注意到近期部分媒体报道,内容有关公司有意于阿布扎比进行第二上市。谨此知会股东及投资者,本公司不时考虑及评估上市后的各项资本运作,包括于其他资本市场进行第二上市之可行性。然而,公司目前尚无任何第二上市确实计划。公司将于有任何重大进展时,根据《香港联合交易所有限公司证券上市规则》适时作出进一步公告。